More results...
Scientific awards – which honor research that makes people laugh and then think – to move away from ‘unsafe’ USThe annual Ig Nobels, a satirical award for scientific achievement, are shifting for the first time from the US to Europe due to concerns abo…
Federal meteorologists say the continental United States just had its second-warmest winter on record, even as many endure bitter cold.
As the US space agency misses its launch window for the second month, smaller firms continue work on their partsIt was shaping up into another ordinary day at the Colorado headquarters of the small space startup Lunar Outpost last Friday when chief exe…
NASA knocked an asteroid off course in 2022 in a pioneering test of humanity’s ability to defend Earth. Its spacecraft’s impact pushed the space rock into a slightly different orbit around the Sun, according to new research published Friday.
Chief medical adviser warns of side-effects and calls for action on junk food advertising and making food healthierWeight-loss drugs cannot rescue the UK from its deepening obesity crisis and produce unpleasant side-effects for many users, the governme…
Ants could have a $2bn per year-impact on Australia’s economy, researchers say
Cheap semaglutide, the drug in Ozempic and Wegovy, could help millions with diabetes and obesity in 160 countriesWeight-loss jabs such as Wegovy and Ozempic could be made for just $3 a month, according to new analysis, potentially making the treatment …
Forever chemicals may affect bees’ royal jelly used to feed larvae, scientists say
Four cemetery workers dug up and moved more than 100 bodies to resell the burial plots nearly 20 years agoIt was a particularly heinous crime. Four workers at a cemetery near Chicago dug up more than 100 bodies and dumped the remains elsewhere in the g…
Preliminary trials into Zorevunersen find drug to be safe and well tolerated by those with Dravet syndromeScientists have hailed a potentially life-changing drug for children with a hard to treat form of epilepsy, after promising early clinical trial r…